Viewing Study NCT00563758


Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2026-01-19 @ 11:47 AM
Study NCT ID: NCT00563758
Status: TERMINATED
Last Update Posted: 2011-06-16
First Post: 2007-08-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation
Sponsor: Hospital Authority, Hong Kong
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: UW03-313 T/313
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View